Search
Resmed Inc
RMDAdd to Watchlist
235.300USD
-4.010-1.68%
Close 11-06 16:00（ET）
33.10BMarket Cap
22.60P/E TTM
After-hours 19:00 (ET)235.300USD+0.110+0.05%
After-hours 19:00 (ET)Resmed Inc (RMD) Stock Price Target & Forecast
Analyst Rating
Based on 23 analysts giving stock ratings to Resmed Inc in the past month.
Hold
3 Strong Buy
8 Buy
10 Hold
1 Sell
1 Strong Sell
Target Price
265.032USD+15.26%
RMD Analyst Recommendation Trends
In the current month, RMD has received 8 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. RMD average Analyst price target in the last month is 265.032.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
2
3
3
3
3
3
8
8
7
8
9
9
9
10
10
10
10
8
7
8
8
7
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
23
23
21
21
21
21
21
21
RMD Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Illumina Inc
ILMN
4
6
9
2
1
22
Financial Forecasting
Based on analysts' estimates, RMD EPS is projected to reach 2.981 in FY2027Q2, following reported EPS of 2.926 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
2.80
2.89
2.67
2.98
3.06
Actual
2.74
2.65
2.93
--
--
Surprise
-1.87%
-8.30%
+9.47%
--
--
FAQs
What is Resmed Inc's expected revenue for the next quarter?
Resmed Inc's expected revenue is 1.46B.
What is Resmed Inc's price target?
Analysts forecast that Resmed Inc's price target is USD 263.50, with the highest forecast at USD 320.00 and the lowest forecast at USD 210.00.
How have Resmed IncRMD's recent earnings per share performed?
The market expectation was USD 2.93, while Resmed IncRMD's earnings per share (EPS) for the previous quarter was USD 2.65. EPS for the next quarter is expected at USD 2.98.
What is the analyst rating for Resmed Inc?
Based on the ratings of Resmed Inc's stock from 23 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.